ONTX Annual Total Expenses
$20.52 M
+$671.00 K+3.38%
31 December 2023
Summary:
As of January 21, 2025, ONTX annual total expenses is $20.52 million, with the most recent change of +$671.00 thousand (+3.38%) on December 31, 2023. During the last 3 years, it has fallen by -$4.70 million (-18.63%).ONTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Quarterly Total Expenses
$5.27 M
+$750.00 K+16.60%
31 March 2024
Summary:
As of January 21, 2025, ONTX quarterly total expenses is $5.27 million, with the most recent change of +$750.00 thousand (+16.60%) on March 31, 2024. Over the past year, it has increased by +$750.00 thousand (+16.60%).ONTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | +16.6% |
| 3 y3 years | -18.6% | +16.6% |
| 5 y5 years | -16.3% | +16.6% |
ONTX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -70.0% | -85.3% |
Onconova Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $5.27 M(+16.6%) |
| Dec 2023 | $20.52 M(+3.4%) | $4.52 M(-12.2%) |
| Sept 2023 | - | $5.15 M(+10.3%) |
| June 2023 | - | $4.67 M(-24.6%) |
| Mar 2023 | - | $6.19 M(+7.0%) |
| Dec 2022 | $19.85 M(+18.7%) | $5.79 M(+1.6%) |
| Sept 2022 | - | $5.70 M(+36.4%) |
| June 2022 | - | $4.18 M(-0.3%) |
| Mar 2022 | - | $4.19 M(+9.7%) |
| Dec 2021 | $16.72 M(-33.7%) | $3.82 M(-5.6%) |
| Sept 2021 | - | $4.05 M(-13.9%) |
| June 2021 | - | $4.70 M(+13.2%) |
| Mar 2021 | - | $4.15 M(-34.2%) |
| Dec 2020 | $25.22 M(+5.6%) | $6.31 M(-0.4%) |
| Sept 2020 | - | $6.34 M(-14.3%) |
| June 2020 | - | $7.39 M(+42.8%) |
| Mar 2020 | - | $5.18 M(-10.1%) |
| Dec 2019 | $23.88 M(-2.6%) | $5.76 M(+11.6%) |
| Sept 2019 | - | $5.16 M(-8.7%) |
| June 2019 | - | $5.66 M(-22.6%) |
| Mar 2019 | - | $7.31 M(+17.8%) |
| Dec 2018 | $24.51 M(-7.6%) | $6.21 M(+8.6%) |
| Sept 2018 | - | $5.71 M(-6.7%) |
| June 2018 | - | $6.12 M(-5.3%) |
| Mar 2018 | - | $6.47 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $26.52 M(-9.3%) | $6.26 M(-8.9%) |
| Sept 2017 | - | $6.87 M(+7.4%) |
| June 2017 | - | $6.39 M(-8.7%) |
| Mar 2017 | - | $7.00 M(+5.4%) |
| Dec 2016 | $29.25 M(-17.4%) | $6.64 M(+11.3%) |
| Sept 2016 | - | $5.97 M(-22.0%) |
| June 2016 | - | $7.65 M(-15.0%) |
| Mar 2016 | - | $8.99 M(+40.8%) |
| Dec 2015 | $35.43 M(-45.1%) | $6.39 M(-14.8%) |
| Sept 2015 | - | $7.50 M(-17.4%) |
| June 2015 | - | $9.08 M(-27.1%) |
| Mar 2015 | - | $12.46 M(-7.5%) |
| Dec 2014 | $64.54 M(-3.6%) | $13.47 M(-10.2%) |
| Sept 2014 | - | $15.00 M(-11.2%) |
| June 2014 | - | $16.89 M(-11.9%) |
| Mar 2014 | - | $19.18 M(+16.3%) |
| Dec 2013 | $66.97 M(-2.2%) | $16.49 M(-22.3%) |
| Sept 2013 | - | $21.22 M(+61.2%) |
| June 2013 | - | $13.16 M(-18.2%) |
| Mar 2013 | - | $16.10 M(+21.3%) |
| Dec 2012 | $68.47 M(+135.6%) | $13.27 M(-63.0%) |
| Sept 2012 | - | $35.88 M(+327.0%) |
| June 2012 | - | $8.40 M(-23.0%) |
| Mar 2012 | - | $10.91 M |
| Dec 2011 | $29.06 M | - |
FAQ
- What is Onconova Therapeutics annual total expenses?
- What is the all time high annual total expenses for Onconova Therapeutics?
- What is Onconova Therapeutics annual total expenses year-on-year change?
- What is Onconova Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly total expenses year-on-year change?
What is Onconova Therapeutics annual total expenses?
The current annual total expenses of ONTX is $20.52 M
What is the all time high annual total expenses for Onconova Therapeutics?
Onconova Therapeutics all-time high annual total expenses is $68.47 M
What is Onconova Therapeutics annual total expenses year-on-year change?
Over the past year, ONTX annual total expenses has changed by +$671.00 K (+3.38%)
What is Onconova Therapeutics quarterly total expenses?
The current quarterly total expenses of ONTX is $5.27 M
What is the all time high quarterly total expenses for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly total expenses is $35.88 M
What is Onconova Therapeutics quarterly total expenses year-on-year change?
Over the past year, ONTX quarterly total expenses has changed by +$750.00 K (+16.60%)